Malaria Prevention and Treatment
Malaria, an infectious disease transmitted by mosquitoes, is one of the most serious public health problems globally. Every year, there are 247 million cases of malaria worldwide and nearly 800,000 deaths; 90% of these cases occur in Africa.1
Pregnant women and their newborn children are particularly vulnerable to the disease. Eighty-five percent of all deaths from malaria are among children under five 2. In Africa, around 10,000 pregnant women and up to 200,000 infants die as a result of malaria infection during pregnancy.3
Yet malaria is 100% preventable and treatable.
Many countries have made significant strides in combatting malaria but none have reached the Roll Back Malaria (RBM) targets of covering 80% of affected populations with life-saving malaria prevention and treatment measures by 2010.
What Jhpiego Is Doing?
Jhpiego stands as a committed partner of the RBM Partnership to fight malaria worldwide and achieve Millennium Development Goals 4, 5 and 6—reduce malaria morbidity and mortality by half as well as reduce child mortality and improve maternal health. Jhpiego supports efforts worldwide to ensure that pregnant women and their unborn babies are safe from the harmful impact of malaria. Jhpiego’s approach addresses malaria prevention and control comprehensively across the health “continuum of care,” from the community to health facility to national level. Jhpiego also support countries to ensure that young children and adults, in addition to pregnant women, are receiving prevention and treatment for malaria.
For more information, download Jhpiego's malaria brief
1Roll Back Malaria. 2011. What is Malaria? Fact Sheet. Located at: http://www.rbm.who.int/cmc_upload/0/000/015/372/RBMInfosheet_1.htm
2 World Health Organization. 2011. Malaria Fact Sheet. Located at: http://www.who.int/mediacentre/factsheets/fs094/en/
3Jhpiego. 2008. Scaling up Malaria in Pregnancy Programs: What it Takes! Citing World Health Organization (WHO). 2008. Malaria in Pregnancy: Pregnant Women and infants.
Highlights from Jhpiego's portfolio
Through participation in strategic partnerships, Jhpiego has extended its ability to make an impact on malaria globally. As a technical representative in the RBM MIP Working Group, Jhpiego has contributed to efforts that have reprioritized MIP as a core component of MNCH programming. Through participation in the RBM Harmonization Working Group, Jhpiego has contributed to raising awareness among stakeholders and disseminating best practices in malaria prevention and control.
Jhpiego works closely with the RBM regional African networks to support malaria prevention and control efforts in member countries. Jhpiego has supported program reviews in African 18 countries, focusing on malaria comprehensively and MIP, and is expanding reviews to malaria-affected countries in the Near East and Asia.
Jhpiego currently supports malaria programs in 14 countries, such as:
Through MCHIP, Jhpiego supports the National Malaria Control Program in upgrading health workers’ skills in malaria diagnosis, case management, promotion of insecticide-treated bed nets (ITNs), monitoring and evaluation, and MIP control through in-service training, improved supervision, communication messaging and pre-service education.
Jhpiego is partnering with the private sector to improve malaria diagnostics, treatment and prevention messaging as well as to increase community engagement.
Jhpiego conducted a malaria review of India’s successes in malaria prevention and control and existing challenges, including how these challenges are addressed. It is expected that this review will inform ways to accelerate malaria prevention and control in India on an MNCH platform.
Through MCHIP, Jhpiego has supported the development and roll out of new malaria case management protocols as part an Integrated Services Packages for MNCH and sexual and reproductive health/family planning.